Provided by Tiger Trade Technology Pte. Ltd.

Sutro Biopharma Inc

20.49
-0.5500-2.61%
Post-market: 20.490.00000.00%16:20 EDT
Volume:275.11K
Turnover:5.59M
Market Cap:339.46M
PE:-1.18
High:21.51
Open:21.49
Low:19.55
Close:21.04
52wk High:43.85
52wk Low:7.15
Shares:16.57M
Float Shares:10.77M
Volume Ratio:1.01
T/O Rate:2.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.3700
EPS(LYR):-22.4900
ROE:-1810.01%
ROA:-36.08%
PB:-3.29
PE(LYR):-0.91

Loading ...

Sutro Biopharma Inc : Truist Securities Assumes Coverage With Buy Rating; Target Price $50

THOMSON REUTERS
·
Jun 11

Sutro Biopharma shareholders adopt director elections at annual meeting

Reuters
·
Jun 09

Sutro Biopharma Initiated at Overweight by Barclays

Dow Jones
·
May 28

Industry Analysts Just Upgraded Their Sutro Biopharma, Inc. (NASDAQ:STRO) Revenue Forecasts By 46%

Simply Wall St.
·
May 28

Barclays Initiates a Buy Rating on Sutro Biopharma (STRO)

TIPRANKS
·
May 28

H.C. Wainwright Remains a Buy on Sutro Biopharma (STRO)

TIPRANKS
·
May 27

Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Sutro Biopharma (STRO)

TIPRANKS
·
May 22

Sutro Biopharma Inc : Piper Sandler Raises Target Price to $61 From $29

THOMSON REUTERS
·
May 18

Sutro Biopharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 15

Wedbush Upgrades Sutro Biopharma to Outperform From Neutral, Boosts Price Target to $60 From $22

MT Newswires Live
·
May 15

Sutro Biopharma price target raised to $43 from $38 at Leerink

TIPRANKS
·
May 15

Sutro Biopharma, Inc. : H.c. Wainwright Raises Target Price to $50 From $28

THOMSON REUTERS
·
May 15

Analyst Reiterates Buy on Sutro Biopharma, Citing STRO-004 Phase I Readout and Broader ADC Platform Potential

TIPRANKS
·
May 15

Sutro Biopharma Q1 EPS $(2.94) Beats $(3.77) Estimate, Sales $14.523M Beat $8.079M Estimate

Benzinga Earnings
·
May 15

Sutro Biopharma Q1 net loss narrows 49% to $38.48 million; revenue falls 17% to $14.52 million

Reuters
·
May 15

Sutro Biopharma Q1 Loss Narrows, Revenue Declines

MT Newswires Live
·
May 15

BRIEF-Sutro Biopharma Q1 Revenue USD 14.523 Million Vs. IBES Estimate USD 8.08 Million

Reuters
·
May 15

Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights

GlobeNewswire
·
May 15

Sutro Biopharma Inc expected to post a loss of $3.77 a share - Earnings Preview

Reuters
·
May 04

LifeSci Capital Initiates a Buy Rating on Sutro Biopharma (STRO)

TIPRANKS
·
May 01